Nebula Research & Development LLC Celldex Therapeutics, Inc. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 15,169 shares of CLDX stock, worth $313,391. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,169
Previous 14,027
8.14%
Holding current value
$313,391
Previous $354 Million
22.33%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
194Shares Held
69.8MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$173 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$134 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$96.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$80.5 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$77.6 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $966M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...